Evenepoel Pieter, Van Den Bergh Barbara, Naesens Maarten, De Jonge Hylke, Bammens Bert, Claes Kathleen, Kuypers Dirk, Vanrenterghem Yves
Department of Medicine, Division of Nephrology, University Hospital Leuven, Leuven, Belgium.
Clin J Am Soc Nephrol. 2009 Mar;4(3):665-72. doi: 10.2215/CJN.03920808. Epub 2009 Mar 4.
Information on the time course of serum calcium levels after renal transplantation is scanty, especially in the early posttransplantation period. Both the abrupt cessation of calcium-containing phosphorus binders and vitamin D (analogs) at the time of surgery and the recovery of renal function may be hypothesized to affect serum calcium levels in this period.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this prospective observational study, biointact parathyroid hormone, calcidiol, calcitriol, calcium, and phosphorus levels were monitored in 201 renal transplant recipients at the time of transplantation and 3 mo thereafter. In addition, the serum calcium nadir and peak in each individual patient within this time frame were identified and the urinary fractional calcium excretion was determined at month 3.
Serum calcium levels followed a biphasic pattern with a significant decline during the first postoperative week, followed by a significant increase. High pretransplantation parathyroid hormone levels protect against hypocalcemia within the first postoperative week but put patients at risk for hypercalcemia later. These complications, occurring in 41 and 14% of the patients, respectively, most probably reflect inappropriate calcium release from the skeleton, rather than inappropriate renal calcium handling.
Our data indicate that both hypo- and hypercalcemia are prevalent in the early posttransplantation period. Pretransplantation parathyroid function is an important predictor of posttransplantation calcium levels.
关于肾移植后血清钙水平随时间变化的信息较少,尤其是在移植后的早期阶段。手术时含钙磷结合剂和维生素D(类似物)的突然停用以及肾功能的恢复,可能被认为会影响这一时期的血清钙水平。
设计、地点、参与者与测量:在这项前瞻性观察研究中,对201例肾移植受者在移植时及之后3个月监测了生物活性甲状旁腺激素、骨化二醇、骨化三醇、钙和磷水平。此外,确定了每位患者在此时间段内血清钙的最低点和峰值,并在第3个月测定了尿钙排泄分数。
血清钙水平呈双相模式,术后第一周显著下降,随后显著上升。移植前甲状旁腺激素水平高可预防术后第一周的低钙血症,但使患者后期有高钙血症风险。这些并发症分别发生在41%和14%的患者中,很可能反映了骨骼中钙的不适当释放,而非肾脏对钙的处理不当。
我们的数据表明,低钙血症和高钙血症在移植后早期都很常见。移植前甲状旁腺功能是移植后钙水平的重要预测指标。